{
    "organizations": [],
    "uuid": "74193d4615d3ddbdad182c58b21ef42cc9544bdc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pfizer-reports-q4-eps-of-202/brief-pfizer-reports-q4-eps-of-2-02-idUSASB0C2XL",
    "ord_in_thread": 0,
    "title": "BRIEF-Pfizer Reports Q4 EPS Of $2.02",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Pfizer Inc:\n* PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS * Q4 EARNINGS PER SHARE $2.02 * Q4 EARNINGS PER SHARE VIEW $0.56 -- THOMSON REUTERS I/B/E/S\n* QTRLY REVENUE $13,703 MILLION VERSUS $13,627 MILLION * ANTICIPATES REPATRIATION TAX LIABILITY OF APPROXIMATELY $15 BILLION, PAYABLE TO U.S. TREASURY\n* QTRLY INNOVATIVE HEALTH SEGMENT REVENUE $8,218 MILLION VERSUS $7,726 MILLION\n* SEES 2018 REVENUES $53.5 BILLION TO $55.5 BILLION * PROVIDES 2018 FINANCIAL GUIDANCE, INCLUDING REVENUES OF $53.5 TO $55.5 BILLION\n* SEES 2018 ADJUSTED DILUTED EPS $2.90 TO $3.00 * SEES 2018 ADJUSTED RESEARCH AND DEVELOPMENT EXPENSES $7.4 BILLION TO $7.9 BILLION\n* Q4 REVENUE VIEW $13.68 BILLION -- THOMSON REUTERS I/B/E/S\n* PFIZER - OVER NEXT FIVE YEARS, CO PLANS TO INVEST APPROXIMATELY $5.0 BILLION IN CAPITAL PROJECTS IN U.S.\n* FY2018 EARNINGS PER SHARE VIEW $2.78, REVENUE VIEW $53.88 BILLION -- THOMSON REUTERS I/B/E/S\n* PFIZER - ALSO PLANS TO MAKE $500 MILLION CONTRIBUTION TO ITS U.S. PENSION PLAN IN 2018\n* 2018 FINANCIAL GUIDANCE REFLECTS A FULL YEAR CONTRIBUTION FROM CONSUMER HEALTHCARE\n* QTRLY ADJUSTED DILUTED EPS OF $0.62‍​ * CONTINUES TO EXPECT THAT ANY DECISION REGARDING STRATEGIC ALTERNATIVES FOR CONSUMER HEALTHCARE WILL BE MADE DURING 2018\n* PFIZER - ALLOCATED ABOUT $100 MILLION FOR SPECIAL, ONE-TIME BONUS TO BE PAID TO ALL NON-EXECUTIVE COLLEAGUES IN Q1 2018\n* FINANCIAL GUIDANCE FOR 2018 ALSO ASSUMES NO GENERIC COMPETITION FOR LYRICA IN U.S. UNTIL JUNE 2019\n* PFIZER - IN 2018, ANTICIPATES QUARTERLY DIVIDEND PAYMENTS OF $0.34/SHARE OF COMMON STOCK\n* PFIZER - DESPITE ABSORBING $2.1 BILLION IMPACT FROM PRODUCTS THAT LOST MARKETING EXCLUSIVITY, CO WAS STILL ABLE TO ACHIEVE 1% OPERATING. REVENUE GROWTH IN 2017\n* FOURTH-QUARTER 2017 IH OPERATIONAL REVENUE GROWTH WAS NEGATIVELY IMPACTED BY LOWER REVENUES FOR VIAGRA IN U.S.\n* ‍AS A RESULT OF ENACTMENT OF TCJA, Q4 AND FY 2017 PROVISION FOR TAXES ON REPORTED INCOME WAS FAVORABLY IMPACTED BY ABOUT $10.7 BILLION​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T19:57:00.000+02:00",
    "crawled": "2018-01-31T16:11:13.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "pfizer",
        "inc",
        "pfizer",
        "report",
        "result",
        "q4",
        "earnings",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "qtrly",
        "revenue",
        "million",
        "versus",
        "million",
        "anticipates",
        "repatriation",
        "tax",
        "liability",
        "approximately",
        "billion",
        "payable",
        "treasury",
        "qtrly",
        "innovative",
        "health",
        "segment",
        "revenue",
        "million",
        "versus",
        "million",
        "see",
        "revenue",
        "billion",
        "billion",
        "provides",
        "financial",
        "guidance",
        "including",
        "revenue",
        "billion",
        "see",
        "adjusted",
        "diluted",
        "eps",
        "see",
        "adjusted",
        "research",
        "development",
        "expense",
        "billion",
        "billion",
        "q4",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "pfizer",
        "next",
        "five",
        "year",
        "co",
        "plan",
        "invest",
        "approximately",
        "billion",
        "capital",
        "project",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "pfizer",
        "also",
        "plan",
        "make",
        "million",
        "contribution",
        "pension",
        "plan",
        "financial",
        "guidance",
        "reflects",
        "full",
        "year",
        "contribution",
        "consumer",
        "healthcare",
        "qtrly",
        "adjusted",
        "diluted",
        "eps",
        "continues",
        "expect",
        "decision",
        "regarding",
        "strategic",
        "alternative",
        "consumer",
        "healthcare",
        "made",
        "pfizer",
        "allocated",
        "million",
        "special",
        "bonus",
        "paid",
        "colleague",
        "q1",
        "financial",
        "guidance",
        "also",
        "assumes",
        "generic",
        "competition",
        "lyrica",
        "june",
        "pfizer",
        "anticipates",
        "quarterly",
        "dividend",
        "payment",
        "common",
        "stock",
        "pfizer",
        "despite",
        "absorbing",
        "billion",
        "impact",
        "product",
        "lost",
        "marketing",
        "exclusivity",
        "co",
        "still",
        "able",
        "achieve",
        "operating",
        "revenue",
        "growth",
        "ih",
        "operational",
        "revenue",
        "growth",
        "negatively",
        "impacted",
        "lower",
        "revenue",
        "viagra",
        "result",
        "enactment",
        "tcja",
        "q4",
        "fy",
        "provision",
        "tax",
        "reported",
        "income",
        "favorably",
        "impacted",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}